
Actibile 150MG Tab
ZYDUS HEALTHCARE PHARMA - tablet - 150 mg - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Sitaglyn M 50/500 Tab.
You are viewing
Sitaglyn M 50/500 Tab
tablet - 10 S
₹137
₹13.73 per tablet
UNISON PHARMACEUTICALS · tablet - 10 S · Rx
₹56
₹5.64 per tablet
Sitagliptin 50 mg + Metformin hydrochloride 500 mg (tablet)
Type 2 diabetes mellitus to improve blood glucose control along with diet and exercise; used when single therapy is inadequate.
Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon secretion. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity, lowering blood glucose.
Take orally as prescribed, usually twice daily with meals to reduce stomach upset. Swallow tablet whole with water; do not crush/chew. Follow diet/exercise advice and monitor blood glucose regularly.
Common side effects of Sitaglyn M 50/500 Tab may include:

ZYDUS HEALTHCARE PHARMA - tablet - 150 mg - 10 S
Standard delivery
ZYDUS HEALTHCARE PHARMA - tablet - 300 mg - 10 S
Standard delivery
ZYDUS HEALTHCARE PHARMA - 15 GR
Standard delivery

ZYDUS HEALTHCARE PHARMA - tablet - 10 S
Standard delivery

ZYDUS HEALTHCARE PHARMA - tablet - 10 S
Standard delivery

ZYDUS HEALTHCARE PHARMA - tablet - 10 Tablet
Standard delivery

ZYDUS HEALTHCARE PHARMA - lotion - 100 ml
Standard delivery

ZYDUS HEALTHCARE PHARMA - injection - 100 mg - VIAL
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Sitaglyn M 50/500 Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Not for type 1 diabetes or diabetic ketoacidosis. Metformin may rarely cause lactic acidosis—risk increases with kidney impairment, dehydration, severe infection, heart/respiratory failure, liver disease, or heavy alcohol use; assess renal function before and during therapy. Temporarily stop metformin before/at time of iodinated contrast studies and major surgery; restart after renal function is stable. Pancreatitis and severe joint pain have been reported with sitagliptin—seek care for persistent severe abdominal pain. Use caution in elderly and in patients with renal impairment; dose adjustment may be needed based on eGFR.